Skip to main content
Back
Watch Compare

RAPID MICRO BIOSYSTEMS, INC.

Data quality: 100%
RPID
Nasdaq Manufacturing Measuring & Analyzing Instruments
$2.12
$0.00 (0.00%)
Mkt Cap: 97.75 M
Price
$2.15
Mkt Cap
97.75 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 9.65% annually over 5 years — modest growth
Debt/Equity of 0.42 — conservative balance sheet
Negative free cash flow of -31.91 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.09%
Capital efficient — spends only 2.53% of revenue on capex

Growth

Revenue Growth (5Y)
9.65%
Above sector avg (1.82%)
Revenue (1Y)19.74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-95.32%
Below sector avg (-53.34%)
ROIC-58.94%
Net Margin-140.30%
Op. Margin-141.10%

Safety

Debt / Equity
0.42
Above sector avg (0.31)
Current Ratio4.23
Interest Coverage-43.48

Valuation

PE (TTM)
-2.07
Below sector avg (-1.47)
P/B Ratio2.20
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.1 -1.5
P/B 2.2 1.6
ROE % -95.3 -53.3
Net Margin % -140.3 -41.5
Rev Growth 5Y % 9.7 1.8
D/E 0.4 0.3

Analyst Price Target

3 analysts
Buy
Current
$2.12
+277.4%
Target
$8.00
$8.00
$8.00
$8.00
Forecast
Forward P/E -2.57
Forward EPS -$0.82
Est. Revenue 46.45 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.82
-$0.91 – -$0.74
 46.45 M 3
FY2026 -$0.92
-$0.96 – -$0.89
 39.23 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.23 -$0.28 -23.5%
Q32025 -$0.25 -$0.26 -6.1%
Q22025 -$0.25 -$0.27 -6.6%
Q12025 -$0.27 -$0.26 +3.7%

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 19.74% Revenue Growth (3Y) 22.13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9.65% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 33.59 M Net Income (TTM) -47.12 M
ROE -95.32% ROA -58.91%
Gross Margin N/A Operating Margin -141.10%
Net Margin -140.30% Free Cash Flow (TTM) -31.91 M
ROIC -58.94% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.42 Current Ratio 4.23
Interest Coverage -43.48 Asset Turnover 0.42
Working Capital 53.40 M Tangible Book Value 44.33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.07 Forward P/E N/A
P/B Ratio 2.20 P/S Ratio 2.91
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.65%
Market Cap 97.75 M Enterprise Value 97.63 M
Per Share
EPS (Diluted TTM) -1.05 Revenue / Share 0.74
FCF / Share -0.70 OCF / Share -0.68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2.53% FCF Conversion 67.72%
SBC-Adj. FCF -36.25 M Growth Momentum 10.09

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 33.59 M 28.05 M 22.52 M 17.13 M 23.23 M
Net Income -47.12 M -46.89 M -52.47 M -60.81 M -73.52 M
EPS (Diluted) -1.05 -1.08 -1.22 -1.43 -3.94
Gross Profit — — — — —
Operating Income -47.39 M -49.92 M -56.56 M -63.22 M -47.23 M
EBITDA — — — — —
R&D Expenses 13.60 M 14.60 M 12.82 M 12.87 M 9.78 M
SG&A Expenses — — — — —
D&A 3.25 M 3.36 M 3.11 M 2.84 M 1.53 M
Interest Expense 1.09 M — 4.21 M 1.78 M 2.65 M
Income Tax 40,000.0 22,000.0 31,000.0 -576,000.0 91,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 74.85 M 98.17 M 143.45 M 190.65 M 241.17 M
Total Liabilities 41.65 M 22.82 M 25.46 M 26.48 M 20.19 M
Shareholders' Equity 33.21 M 75.35 M 117.99 M 164.17 M 220.98 M
Total Debt 18.90 M — — 0.0 0.0
Cash & Equivalents 20.03 M 16.91 M 24.29 M 27.06 M 178.39 M
Current Assets 61.17 M 80.92 M 120.42 M 138.58 M 218.12 M
Current Liabilities 18.49 M 17.57 M 18.99 M 19.05 M 18.17 M